172 related articles for article (PubMed ID: 31115495)
1. Low‑intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR‑34a/c‑Met axis.
Li P; Zhang J; Li F; Yu Y; Chen Y
Int J Mol Med; 2019 Jul; 44(1):135-144. PubMed ID: 31115495
[TBL] [Abstract][Full Text] [Related]
2. Low‑intensity ultrasound enhances the antitumor effects of doxorubicin on hepatocellular carcinoma cells through the ROS‑miR‑21‑PTEN axis.
Xia C; Zeng H; Zheng Y
Mol Med Rep; 2020 Mar; 21(3):989-998. PubMed ID: 32016465
[TBL] [Abstract][Full Text] [Related]
3. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W
J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814
[TBL] [Abstract][Full Text] [Related]
5. TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growth.
Shen J; Lin H; Li G; Jin RA; Shi L; Chen M; Chang C; Cai X
Oncotarget; 2016 May; 7(22):32088-99. PubMed ID: 27050071
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
7. miR‑576‑3p overexpression enhances cisplatin sensitivity of ovarian cancer cells by dysregulating PD‑L1 and cyclin D1.
Zuo Y; Zheng W; Tang Q; Liu J; Wang S; Xin C
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236151
[TBL] [Abstract][Full Text] [Related]
8. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
Cao F; Yin LX
Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of hepatocellular carcinoma cells to irradiation by miR‑34a through targeting lactate dehydrogenase‑A.
Li X; Lu P; Li B; Yang R; Chu Y; Zhang Z; Wan H; Niu C; Wang C; Luo K
Mol Med Rep; 2016 Apr; 13(4):3661-7. PubMed ID: 26956717
[TBL] [Abstract][Full Text] [Related]
10. Strategy of differentiation therapy: effect of dual-frequency ultrasound on the induction of liver cancer stem-like cells on a HA-based multilayer film system.
Lee IC; Fadera S; Liu HL
J Mater Chem B; 2019 Sep; 7(35):5401-5411. PubMed ID: 31414097
[TBL] [Abstract][Full Text] [Related]
11. A small-molecule modulator of the tumor-suppressor miR34a inhibits the growth of hepatocellular carcinoma.
Xiao Z; Li CH; Chan SL; Xu F; Feng L; Wang Y; Jiang JD; Sung JJ; Cheng CH; Chen Y
Cancer Res; 2014 Nov; 74(21):6236-47. PubMed ID: 25217526
[TBL] [Abstract][Full Text] [Related]
12. MiRNA-206 inhibits hepatocellular carcinoma cell proliferation and migration but promotes apoptosis by modulating cMET expression.
Wang Y; Tai Q; Zhang J; Kang J; Gao F; Zhong F; Cai L; Fang F; Gao Y
Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):243-253. PubMed ID: 30805592
[TBL] [Abstract][Full Text] [Related]
13. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
[TBL] [Abstract][Full Text] [Related]
14. miR-21-5p Suppressed the Sensitivity of Hepatocellular Carcinoma Cells to Cisplatin by Targeting FASLG.
Chen S; Yang C; Sun C; Sun Y; Yang Z; Cheng S; Zhuge B
DNA Cell Biol; 2019 Aug; 38(8):865-873. PubMed ID: 31225740
[TBL] [Abstract][Full Text] [Related]
15. MiR-124 sensitizes cisplatin-induced cytotoxicity against CD133
Xu Y; Lai Y; Weng H; Tan L; Li Y; Chen G; Luo X; Ye Y
Aging (Albany NY); 2019 May; 11(9):2551-2564. PubMed ID: 31056532
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of cisplatin-based TACE by a hemoglobin-based oxygen carrier in an orthotopic rat HCC model.
Liu XB; Cheng Q; Geng W; Ling CC; Liu Y; Ng KT; Yam JW; Guan XY; Lo CM; Man K
Artif Cells Nanomed Biotechnol; 2014 Aug; 42(4):229-36. PubMed ID: 23795724
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma.
Phan LM; Fuentes-Mattei E; Wu W; Velazquez-Torres G; Sircar K; Wood CG; Hai T; Jimenez C; Cote GJ; Ozsari L; Hofmann MC; Zheng S; Verhaak R; Pagliaro L; Cortez MA; Lee MH; Yeung SC; Habra MA
Cancer Res; 2015 Oct; 75(19):4131-42. PubMed ID: 26282167
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET.
Wei B; Huang QY; Huang SR; Mai W; Zhong XG
Mol Med Rep; 2015 Oct; 12(4):5255-61. PubMed ID: 26238271
[TBL] [Abstract][Full Text] [Related]
20. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
Li Y; Ye Y; Feng B; Qi Y
J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
